AstraZeneca receives two NICE recommendations for lung cancer patients
AstraZeneca has received two positive recommendations from the National Institute for Health and Care Excellence (NICE) for lung cancer patients across England and Wales. Tagrisso (osimertinib) has been granted positive recommendation for NHS use as an …